Aemetis (NASDAQ:AMTX) Price Target Raised to $19.00 at Ascendiant Capital Markets

Aemetis (NASDAQ:AMTX) had its price target boosted by Ascendiant Capital Markets from $18.00 to $19.00 in a research report report published on Monday,Benzinga reports. They currently have a buy rating on the specialty chemicals company’s stock.

Other equities analysts also recently issued reports about the company. HC Wainwright reissued a “buy” rating and set a $28.00 price objective on shares of Aemetis in a research report on Friday. StockNews.com raised Aemetis to a “sell” rating in a research report on Wednesday, February 5th. One investment analyst has rated the stock with a sell rating, one has given a hold rating and three have issued a buy rating to the company. According to MarketBeat.com, Aemetis has a consensus rating of “Hold” and an average target price of $14.56.

Aemetis Price Performance

NASDAQ AMTX opened at $2.04 on Monday. The company has a market cap of $104.35 million, a P/E ratio of -0.90 and a beta of 1.48. The stock has a 50-day moving average of $2.16 and a two-hundred day moving average of $2.67. Aemetis has a 1-year low of $1.50 and a 1-year high of $7.03.

Institutional Trading of Aemetis

A number of large investors have recently made changes to their positions in the stock. Price T Rowe Associates Inc. MD lifted its position in Aemetis by 16.1% during the fourth quarter. Price T Rowe Associates Inc. MD now owns 38,016 shares of the specialty chemicals company’s stock worth $103,000 after buying an additional 5,281 shares during the period. Tower Research Capital LLC TRC raised its holdings in shares of Aemetis by 128.8% in the 4th quarter. Tower Research Capital LLC TRC now owns 10,407 shares of the specialty chemicals company’s stock worth $28,000 after purchasing an additional 5,859 shares during the period. Barclays PLC raised its holdings in shares of Aemetis by 14.7% in the 4th quarter. Barclays PLC now owns 54,492 shares of the specialty chemicals company’s stock worth $146,000 after purchasing an additional 6,996 shares during the period. Wells Fargo & Company MN raised its holdings in shares of Aemetis by 20.0% in the 4th quarter. Wells Fargo & Company MN now owns 45,741 shares of the specialty chemicals company’s stock worth $123,000 after purchasing an additional 7,622 shares during the period. Finally, FMR LLC raised its holdings in shares of Aemetis by 68.2% in the 3rd quarter. FMR LLC now owns 22,531 shares of the specialty chemicals company’s stock worth $52,000 after purchasing an additional 9,137 shares during the period. Institutional investors and hedge funds own 27.02% of the company’s stock.

About Aemetis

Aemetis, Inc operates as a renewable natural gas and renewable fuels company. It operates through three segments: California Ethanol, California Dairy Renewable Natural Gas, and India Biodiesel. The company focuses on the operation, acquisition, development, and commercialization of technologies to produce low and negative carbon intensity renewable fuels that replace fossil-based products.